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Background
The Quantiferon-CMV assay is a test for Cell Mediated
Immune (CMI) responses to peptide antigens that simu-
late CMV proteins. Individuals infected with CMV
usually have CD8+ lymphocytes in their blood that
recognize these antigens. This recognition process
involves the generation and secretion of the cytokine
and interferon (IFN). The detection and subsequent
quantification of IFN forms the basis of this test.
Purpose of the study
To evaluate the accuracy of Quantiferon-CMV assay in
diagnosis of CMV infection in HIV positive patients and
compare it with older ELISA method.
Methods
This is a prospective study on a group of 48 HIV
infected patients that are in a constant supervision of
the Regional HIV Centre Constanta, Romania. The
patients were tested by Quantiferon-CMV assay and by
CMV ELISA. In the study were included adults patients
with known HIV infection and CD4 < 200 cells/mm3,
asymptomatic or with suggestive clinical manifestations:
neurological (central or peripheral), ocular, gastrointest-
inal, pancreatic or hepatic symptoms. The patients with
other associated opportunistic infections were excluded
from the study.
Results
Sixteen women and 32 men were included in the study,
with a mean age of 32.8 years (range between 20-62
years), of whom three were antiretroviral naive patients
and 45 were multiple experienced. Of these, seven
patients were asymptomatic, 41 had different clinical
manifestations: pancreatitis (12), esophagitis (3), gastritis
(2) colitis (6), liver involvement (9), cholecystitis (7),
central and peripheral nervous system involvement (8)
retinitis (4). IgM ELISA was negative in all cases, IgG
ELISA was positive in 45 patients (95.5%) and Quanti-
feron-CMV assay was reactive in 38 cases (79.1%). All
patients with CD4 < 50 cells/mm3 with clinical manifes-
tations showed both positive reactions (14 patients). The
patients who were treated with gancyclovir for CMV
retinitis showed positive ELISA IgG, but negative Quan-
tiferon-CMV assay. The sensitivity of Quantiferon-CMV
assay was 92.7%.
Conclusions
Quantiferon-CMV assay has increased sensitivity in the
detection of CMV reactivation induced by severe immu-
nodepression (92.7%). There is a strong correlation (p <
0.01) between severe immunodepression (CD4 < 50
cells/mm3) and CMV reactivation detected by Quanti-
feron. This test is easy accessible and an efficient
method of monitoring therapy with gancyclovir.
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